Skip to content

Boustead Holdings

Boustead Holdings is a Malaysian diversified corporation with interests in property, pharmaceuticals, heavy industries, trading, finance and investment.

Last updated August 26, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Boustead Holdings Berhad is a Malaysian diversified corporate group headquartered in Kuala Lumpur. Its origins date to 1828, when English businessman Edward Boustead established Boustead & Co in Singapore. The historic business later developed into a group of related companies operating in several countries and across multiple sectors. The Malaysian entity was incorporated in 1961 and is listed on Bursa Malaysia's Main Market under the ticker MYX:2771. The company operates through a broad portfolio rather than a single consumer-facing product category. Its principal activities include property development and investment, hotel management, industrial manufacturing, pharmaceuticals, defence and marine engineering, petroleum retailing, financial services, travel and tourism, and related distribution and logistics activities. The group has been described as having more than 16,000 employees across over 90 listed and unlisted companies in Malaysia, Indonesia and the United Kingdom. Boustead's property and industrial interests include development and investment projects, project management, hotel operations under the Royale Chulan chain, and the manufacture and distribution of cellulose fibre cement products. The group also operates The Curve shopping mall in Damansara, Selangor, which is connected to an IKEA store. These activities place Boustead in both commercial real estate and hospitality, alongside its industrial businesses. Through its pharmaceutical interests, particularly Pharmaniaga, Boustead participates in research and development, generic-drug and over-the-counter medicine manufacturing, nutraceuticals, pharmaceutical logistics and distribution, regulatory services, sales and marketing, and retail pharmacy. Pharmaniaga is described as Malaysia's largest listed pharmaceutical group. During the COVID-19 pandemic, Pharmaniaga was appointed to distribute Sinovac's vaccine in the Malaysian market. The heavy-industries division, associated with Boustead Heavy Industries Corporation, serves defence, maritime and aerospace markets. Its capabilities include shipbuilding, ship repair, maintenance, repair and overhaul, component and systems manufacturing, maritime training, and integrated logistics support. The division serves government and commercial customers and reflects Boustead's longstanding relationship with Malaysia's defence and security ecosystem. Boustead also maintains interests in trading, finance and investment. These include a Malaysian petroleum retail network operating under the BHPetrol name, financial products, and travel and tourism-related services. The Armed Forces Fund Board, Malaysia's military pension-fund statutory body, is the group's major shareholder. Boustead is therefore both a diversified commercial group and an important corporate affiliate of Malaysia's military institutional sphere. The present Boustead organization emerged from a major restructuring of the historic Boustead business in 1975. That reorganization produced four entities: Boustead plc in London, later reorganized as Boustead & Co; Boustead Holdings Berhad in Malaysia; Boustead Singapore Limited; and Boustead China Co Ltd. Boustead Holdings represents the Malaysian corporate branch of this wider historical lineage.

History

Boustead Holdings traces its origins to Boustead & Co, established in Singapore in 1828 by Edward Boustead, an English businessman. The original enterprise formed part of a wider British commercial network in Southeast Asia. Over time, the Boustead name became associated with a range of trading and investment activities, and its corporate identity evolved as the business was reorganized across different jurisdictions. The Malaysian company was incorporated in 1961 as Boustead Holdings Berhad. Its later development took place within the expanding Malaysian economy, where diversified groups were active in sectors such as property, manufacturing, finance, trading and industrial services. Boustead's Malaysian operations eventually grew beyond a single line of business and became organized around several divisions serving important parts of the domestic economy. A significant restructuring occurred in 1975. Boustead & Co was separated into four entities: Boustead plc in London, which was later reorganized as Boustead & Co; Boustead Holdings Berhad in Malaysia; Boustead Singapore Limited; and Boustead China Co Ltd. This division created distinct corporate vehicles while preserving the historical Boustead name in several markets. Boustead Holdings became the principal Malaysian branch of that lineage. The group subsequently built a portfolio covering property and industrial activities, pharmaceuticals, heavy industries, trading, finance and investment. In property and industrial operations, it developed and invested in real estate, managed hotels, undertook project management and manufactured and distributed cellulose fibre cement products. Its hospitality activities include the Royale Chulan hotel chain, while its retail-property portfolio includes The Curve mall in Damansara, Selangor. Pharmaceuticals became another major area of activity through Pharmaniaga. The business spans pharmaceutical research and development, production of generic and over-the-counter medicines, nutraceuticals, logistics, distribution, regulatory work, marketing and retail pharmacy. Pharmaniaga's role expanded during the COVID-19 pandemic when it was appointed to distribute Sinovac vaccine products in Malaysia. Boustead's heavy-industries activities are associated with Boustead Heavy Industries Corporation and cover defence, maritime and aerospace services. The division provides shipbuilding, ship repair, maintenance, repair and overhaul, manufacturing of components and systems, maritime training and integrated logistics support. Its customer base includes Malaysian government entities as well as commercial clients. This business contributes to Boustead's position as an affiliate of Malaysia's military and defence institutional system. The group's trading, finance and investment activities include a Malaysian petroleum retail network operating under the BHPetrol name, financial products and travel and tourism services. The Armed Forces Fund Board, a statutory Malaysian military pension fund, is the major shareholder. This ownership relationship links Boustead's commercial portfolio with a significant national institutional investor. Boustead Holdings is listed on Bursa Malaysia's Main Market. The group has been described as operating through more than 90 listed and unlisted companies and employing more than 16,000 people across Malaysia, Indonesia and the United Kingdom. Its corporate model is therefore that of a diversified Malaysian holding and operating group rather than a narrowly defined consumer brand.

  • 1975

    Historic Boustead business is divided into four entities

    [1]

    The wider Boustead business is reorganized into entities in London, Malaysia, Singapore and China.

  • 1961

    Boustead Holdings Berhad is incorporated

    [1]

    The Malaysian corporate entity is incorporated.

  • 1828

    Boustead & Co is established in Singapore

    [1]

    Edward Boustead establishes the business that forms the historical origin of the Boustead corporate group.

  • Boustead Holdings is listed on Bursa Malaysia

    [1]

    Boustead Holdings becomes a company listed on Bursa Malaysia's Main Market under MYX:2771; the source does not specify the listing year.

  • Pharmaniaga distributes Sinovac vaccine in Malaysia

    [1]

    The Boustead subsidiary is appointed to distribute Sinovac's COVID-19 vaccine for the Malaysian market.

Products and positioning

A diversified Malaysian investment and operating group spanning strategic sectors of the national economy, with particular strengths in pharmaceuticals, defence-related heavy industries, property, hospitality and petroleum retailing.

  • Hotels and hospitality

    Royale Chulan

    Royale Chulan is Boustead's hotel and hospitality chain within its property and industrial division. It represents the group's participation in hotel management and hospitality operations rather than a standalone consumer-goods product line.

  • Pharmaceuticals

    Pharmaniaga

    Pharmaniaga is Boustead's pharmaceutical subsidiary and is described as Malaysia's largest listed pharmaceutical group. Its activities cover research and development, generic and over-the-counter medicines, nutraceuticals, logistics, distribution, regulatory services, sales and marketing, and retail pharmacy.

  • Petroleum retail

    BHPetrol

    BHPetrol is Boustead's home-grown Malaysian retail petroleum network. It forms part of the group's trading, finance and investment division and gives Boustead a direct operating presence in fuel retailing.

  • Defence, marine and aerospace services

    Boustead Heavy Industries Corporation

    Boustead Heavy Industries Corporation provides defence, maritime and aerospace capabilities, including shipbuilding, ship repair, maintenance, repair and overhaul, component and systems manufacturing, maritime training and integrated logistics support for government and commercial customers.

  • Shopping mall and commercial property

    The Curve

    The Curve is a shopping mall operated by Boustead in Damansara, Selangor. The mall is connected to an IKEA store and forms part of the group's property and investment portfolio.

  • Building materials

    Cellulose fibre cement products

    Boustead's property and industrial division manufactures and distributes cellulose fibre cement products, extending the group's activities into industrial and construction-related materials.

Controversies

  • 2020

    Boustead Holdings sues former directors

    Boustead Holdings filed a suit against its former chairman, managing director and four other former directors, alleging breach of fiduciary duty and seeking £6.4 million.

Read more

Recent events

  • Boustead Holdings sues former directors[2]

    Boustead Holdings filed a suit against its former chairman, managing director and four other former directors, alleging breach of fiduciary duty and seeking £6.4 million.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/boustead-holdings · Editorial policy · How profiles are compiled